Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

Samsung Medical Center

Status: Completed

Conditions: Neuromyelitis Optica Spectrum Disorder (NMOSD)

Study type: Observational

Funder types: Other

Identifiers

NCT07032337

IST_NMOSD

Details and patient eligibility

About

Newly diagnosed NMOSD patients

Full description

From 2011 to 2022, newly diagnosed NMOSD patients who had not previously claimed NMOSD. Exclusion criteria were history of cancer or had used ISTs (excluding steroids) prior to the NMOSD diagnosis.

Enrollment: 2,985 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• From 2011 to 2022, newly diagnosed NMOSD patients..

Exclusion criteria

• Patients had a history of cancer
• Patients had used ISTs (excluding steroids) prior to the NMOSD diagnosis.

Trial design

2,985 participants in 2 patient groups

IST group

Description:

patients who initiated any ISTs

non-IST group

Description:

patients who did not initiate any ISTs